| Company/Division name | Eli Lilly |
| Parent company | Eli Lilly and Company |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 450 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2032 |
| Capital investment ($): | 6000 |
| City reshored to: | Huntsville |
| State(s) reshored to: | AL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What non-domestic negative factors made offshoring less attractive? | Green considerations, Supply chain interruption, Tariffs |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Higher productivity, Infrastructure, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training |
